![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: BOC |
Gene summary for BOC |
![]() |
Gene information | Species | Human | Gene symbol | BOC | Gene ID | 91653 |
Gene name | BOC cell adhesion associated, oncogene regulated | |
Gene Alias | Boi | |
Cytomap | 3q13.2 | |
Gene Type | protein-coding | GO ID | GO:0000902 | UniProtAcc | Q9BWV1 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
91653 | BOC | C43 | Human | Oral cavity | OSCC | 3.94e-04 | -1.61e-01 | 0.1704 |
91653 | BOC | LP17 | Human | Oral cavity | LP | 1.48e-03 | 8.62e-01 | 0.2349 |
91653 | BOC | SYSMH3 | Human | Oral cavity | OSCC | 3.61e-06 | 2.86e-01 | 0.2442 |
91653 | BOC | SYSMH4 | Human | Oral cavity | OSCC | 1.88e-13 | 5.17e-01 | 0.1226 |
91653 | BOC | P1_S1_AK | Human | Skin | AK | 3.48e-06 | 4.09e-01 | -0.3399 |
91653 | BOC | P2_S3_AK | Human | Skin | AK | 2.72e-06 | 4.16e-01 | -0.3287 |
91653 | BOC | P3_S6_AK | Human | Skin | AK | 1.56e-03 | 3.04e-01 | -0.3256 |
91653 | BOC | P4_S8_cSCC | Human | Skin | cSCC | 1.22e-05 | 2.14e-01 | -0.3095 |
91653 | BOC | P1_cSCC | Human | Skin | cSCC | 6.66e-08 | 4.18e-01 | 0.0292 |
91653 | BOC | P2_cSCC | Human | Skin | cSCC | 4.57e-14 | 4.63e-01 | -0.024 |
91653 | BOC | male-WTA | Human | Thyroid | PTC | 1.71e-14 | 1.76e-01 | 0.1037 |
91653 | BOC | PTC01 | Human | Thyroid | PTC | 1.04e-06 | 1.82e-01 | 0.1899 |
91653 | BOC | PTC04 | Human | Thyroid | PTC | 7.59e-13 | 3.02e-01 | 0.1927 |
91653 | BOC | PTC05 | Human | Thyroid | PTC | 9.59e-03 | 1.10e-01 | 0.2065 |
91653 | BOC | PTC06 | Human | Thyroid | PTC | 9.20e-14 | 3.72e-01 | 0.2057 |
91653 | BOC | PTC07 | Human | Thyroid | PTC | 1.22e-32 | 5.20e-01 | 0.2044 |
91653 | BOC | ATC12 | Human | Thyroid | ATC | 1.41e-10 | 1.60e-01 | 0.34 |
91653 | BOC | ATC13 | Human | Thyroid | ATC | 3.53e-04 | 1.46e-01 | 0.34 |
91653 | BOC | ATC4 | Human | Thyroid | ATC | 8.51e-11 | 2.02e-01 | 0.34 |
91653 | BOC | ATC5 | Human | Thyroid | ATC | 9.00e-07 | 1.70e-01 | 0.34 |
Page: 1 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00454453 | Oral cavity | OSCC | myoblast differentiation | 46/7305 | 84/18723 | 2.43e-03 | 1.07e-02 | 46 |
GO:006156410 | Oral cavity | OSCC | axon development | 207/7305 | 467/18723 | 1.01e-02 | 3.51e-02 | 207 |
GO:004544512 | Oral cavity | LP | myoblast differentiation | 35/4623 | 84/18723 | 4.56e-04 | 4.33e-03 | 35 |
GO:0045661 | Oral cavity | LP | regulation of myoblast differentiation | 22/4623 | 51/18723 | 2.96e-03 | 2.03e-02 | 22 |
GO:006156416 | Skin | AK | axon development | 91/1910 | 467/18723 | 8.60e-10 | 8.63e-08 | 91 |
GO:000740916 | Skin | AK | axonogenesis | 80/1910 | 418/18723 | 2.07e-08 | 1.19e-06 | 80 |
GO:00074112 | Skin | AK | axon guidance | 42/1910 | 227/18723 | 1.01e-04 | 1.33e-03 | 42 |
GO:00974852 | Skin | AK | neuron projection guidance | 42/1910 | 228/18723 | 1.11e-04 | 1.43e-03 | 42 |
GO:00454455 | Skin | AK | myoblast differentiation | 16/1910 | 84/18723 | 1.01e-02 | 4.84e-02 | 16 |
GO:004544513 | Skin | cSCC | myoblast differentiation | 35/4864 | 84/18723 | 1.23e-03 | 7.97e-03 | 35 |
GO:006156422 | Skin | cSCC | axon development | 146/4864 | 467/18723 | 5.50e-03 | 2.73e-02 | 146 |
GO:006156419 | Thyroid | PTC | axon development | 199/5968 | 467/18723 | 5.27e-07 | 8.53e-06 | 199 |
GO:000740918 | Thyroid | PTC | axonogenesis | 178/5968 | 418/18723 | 2.17e-06 | 2.91e-05 | 178 |
GO:006156423 | Thyroid | ATC | axon development | 220/6293 | 467/18723 | 6.85e-10 | 1.80e-08 | 220 |
GO:000740919 | Thyroid | ATC | axonogenesis | 197/6293 | 418/18723 | 5.09e-09 | 1.13e-07 | 197 |
GO:00074113 | Thyroid | ATC | axon guidance | 96/6293 | 227/18723 | 3.74e-03 | 1.63e-02 | 96 |
GO:00974853 | Thyroid | ATC | neuron projection guidance | 96/6293 | 228/18723 | 4.36e-03 | 1.81e-02 | 96 |
GO:0007224 | Thyroid | ATC | smoothened signaling pathway | 60/6293 | 138/18723 | 9.75e-03 | 3.57e-02 | 60 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0436014 | Oral cavity | OSCC | Axon guidance | 97/3704 | 182/8465 | 5.59e-03 | 1.33e-02 | 6.76e-03 | 97 |
hsa0436015 | Oral cavity | OSCC | Axon guidance | 97/3704 | 182/8465 | 5.59e-03 | 1.33e-02 | 6.76e-03 | 97 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
BOC | SNV | Missense_Mutation | rs772475137 | c.1508N>T | p.Ala503Val | p.A503V | Q9BWV1 | protein_coding | tolerated(0.16) | benign(0.005) | TCGA-BR-6566-01 | Stomach | stomach adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
BOC | SNV | Missense_Mutation | c.2846N>T | p.Pro949Leu | p.P949L | Q9BWV1 | protein_coding | deleterious_low_confidence(0.05) | benign(0.003) | TCGA-BR-8078-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
BOC | SNV | Missense_Mutation | rs138233485 | c.1444C>T | p.Arg482Cys | p.R482C | Q9BWV1 | protein_coding | deleterious(0) | probably_damaging(0.994) | TCGA-BR-8361-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
BOC | SNV | Missense_Mutation | c.2215N>A | p.Ala739Thr | p.A739T | Q9BWV1 | protein_coding | deleterious(0.02) | possibly_damaging(0.531) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR | |
BOC | SNV | Missense_Mutation | c.3286N>G | p.Met1096Val | p.M1096V | Q9BWV1 | protein_coding | tolerated_low_confidence(0.41) | benign(0) | TCGA-BR-8680-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | oxaliplatin | CR | |
BOC | SNV | Missense_Mutation | rs116501937 | c.2611G>A | p.Val871Ile | p.V871I | Q9BWV1 | protein_coding | tolerated(0.19) | benign(0.411) | TCGA-D7-A4YU-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Chemotherapy | capecitabine | SD |
BOC | SNV | Missense_Mutation | rs780959946 | c.2047C>T | p.Arg683Trp | p.R683W | Q9BWV1 | protein_coding | deleterious(0.01) | probably_damaging(0.992) | TCGA-D7-A4YV-01 | Stomach | stomach adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
BOC | SNV | Missense_Mutation | rs745591558 | c.583N>A | p.Glu195Lys | p.E195K | Q9BWV1 | protein_coding | tolerated(0.21) | benign(0.115) | TCGA-HU-8238-01 | Stomach | stomach adenocarcinoma | Male | <65 | III/IV | Chemotherapy | didox | SD |
BOC | SNV | Missense_Mutation | rs141457641 | c.2074N>A | p.Glu692Lys | p.E692K | Q9BWV1 | protein_coding | tolerated(0.16) | benign(0.231) | TCGA-HU-A4H8-01 | Stomach | stomach adenocarcinoma | Male | >=65 | I/II | Chemotherapy | didox | PD |
BOC | SNV | Missense_Mutation | novel | c.470N>A | p.Pro157His | p.P157H | Q9BWV1 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-RD-A8NB-01 | Stomach | stomach adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | PD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |